▶️ Organización Mundial de la Salud. Informe global de resistencia a los antimicrobianos sobre vigilancia: resumen de 2014. 2014. Disponible en: http://apps.who.int/iris/bitstream/10665/112647/1/ WHO_HSE_PED_AIP_2014.2_eng.pdf? Ua = 1 (consultado en abril de 2019)
▶️ Goossens H, y col. Lancet 2005; 365: 579–87;
▶️ Organización Mundial de la Salud. La evolución de la amenaza de resistencia a los antimicrobianos. Opciones para la acción. 2012. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/44812/9789241503181_eng.pdf?sequence=1 (consultado en abril de 2019)
▶️ Riedel S, y col. Eur J Clin Microbiol Infect Dis 2007; 26: 485–90;
▶️ Cassini A, y col. Lancet Infect Dis 2019; 19: 56–66;
▶️ Centros de control y prevención de enfermedades. Amenazas de resistencia a los antibióticos en los Estados Unidos, 2013. Disponible en: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf (consultado en abril de 2019)
▶️ NCCID. Resistencia antimicrobiana adquirida en la comunidad. Notas de consulta. Febrero de 2010. Disponible en: https://nccid.ca/wp-content/uploads/sites/2/2015/04/caAMR_ConsultationNotes_final.pdf (consultado en abril de 2019).
▶️ Organización Mundial de la Salud. Informe del sistema mundial de vigilancia de la resistencia a los antimicrobianos (GLASS) 2016–2017. 2018. Disponible en: https://www.who.int/glass/resources/publications/early-implementation-report/en/ (consultado en abril de 2019)
▶️ Kapoor G, y col. J Anaesthesiol Clin Pharmacol 2017; 33: 300–5;
▶️ Munita JM, Arias CA. Microbiol Spectr 2016
▶️ Hershberg R. Cold Spring Harb Perspect Biol 2015; 7: a018077
▶️ Smith RA, y col. Health Commun 2015; 30: 309–14;
▶️ Cantón R, Morosini MI. FEMS Microbiol Rev 2011; 35: 977–91
▶️ Goossens H, y col. Lancet 2005; 365: 579–87;
▶️ Riedel S, y col. Eur J Clin Microbiol Infect Dis 2007; 26: 485–90
▶️ van Duijn HJ y col. Br J Gen Pract 2007; 57: 561–8;
▶️ Organización Mundial de la Salud. Plan de acción mundial sobre resistencia a los antimicrobianos, 2015. Disponible en: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/(accedido en abril de 2019);
▶️ Zaman SB, y col. Cureus 2017; 9: e1403
▶️ Organización Mundial de la Salud. Resistencia antimicrobiana. Factsheet 194. Abril de 2014. Disponible en: http://www.who.int/mediacentre/factsheets/fs194/en/ (consultado en abril de 2019);
▶️ Organización Mundial de la Salud. Diez hechos sobre la resistencia a los antimicrobianos. 2017. Disponible en: http://www.who.int/features/factfiles/antimicrobial_resistance/en/ (consultado en abril de 2019);
▶️ Oxford J, y col. Educ Prim Care 2013; 24: 291–3;
▶️ Informe técnico conjunto ECDC / EMEA: El desafío bacteriano: tiempo de reacción. 2009. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2009/ 11 / WC500008770.pdf (consultado en abril de 2019);
▶️ IDSA. Datos sobre la resistencia a los antibióticos. Abril de 2011. Disponible en: https://www.idsociety.org/public-health/antimicrobial-resistance/archive-antimicrobial-resistance/facts-about-antibiotic-resistance (consultado en abril de 2019);
▶️ Del Mar C, y col. Aust Fam Physician 2012; 41: 839–40
▶️ Francis NA, et al. BMJ 2009;339:b2885; 2. Van Duijn HJ, et al. Br J Gen Pract 2007;57:561–8;
▶️ Kenealy T, Arroll B. Cochrane Database Syst Rev 2013;6:CD000247;
▶️ Thomas M, Bomar PA. Upper respiratory tract infection. 2018. Available at https://www.ncbi.nlm.nih.gov/books/NBK532961/ (accessed April 2019);
▶️ Global Burden of Disease Study 2013 CollaboratorsLancet 2015;386:743–800
▶️ Eccles R. Lancet Infect Dis 2005;5:718–25;
▶️ Baron S. Medical Microbiology 4th edition. Chapter 93. Infections of the Respiratory System. 1996. University of Texas Medical Branch at Galveston, Galveston, Texas;
▶️ Francis NA, et al. BMJ 2009;339:b2885
▶️ Hildreth CJ, et al. JAMA 2009;302:816; 2. Shulman ST, et al. Clin Infect Dis 2012;55:e86–102;
▶️ Centor RM, et al. Med Decis Making 1981;1:239–46;
▶️ Altiner A, et al. Scan J Prim Health Care 2009;27:70–3;
▶️ van Duijn HJ, et al. Br J Gen Pract 2007;57:561–8;
▶️ Worrall GJ. Can Fam Physician 2007;53:1961–2;
▶️ Fashner J, et al. Am Fam Physician 2012;86:153–9;
▶️ Jefferson T, et al. Cochrane Database Syst Rev 2011;1:CD006207
▶️ Ebell MH, et al. JAMA 2000;284:2912–8;
▶️ Hildreth CJ, et al. JAMA 2009;302:816;
▶️ Mazzaglia G, et al. Eur J Clin Pharmacol 2003;59:651–7;
▶️ World Health Organization. Global action plan on antimicrobial resistance, 2015. Available at: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/ (accessed April 2019);
▶️ Special Eurobarometer 338. Antimicrobial resistance. Survey carried out by TNS Opinion & Social at the request of the Directorate-General for Health and Consumers. 2010. Available at: https://ec.europa.eu/health/sites/health/files/antimicrobial_resistance/docs/ebs_338_en.pdf (accessed April 2019);
▶️ Thamlikitkul V, Apisitwittaya W. Int J Infect Dis 2004;8:47–51;
▶️ Ganguly NK, et al. Indian J Med Res 2011;134:281–94;
▶️ Scott JG, et al. J Fam Pract 2001;50:853–8;
▶️ Costelloe C, et al. BMJ 2010;340:c2096;
▶️ Kim SH, et al. Antimicrob Agents Chemother 2012;56:1418–26;
▶️ World Health Organization. Antimicrobial resistance. Factsheet 194 Available at: http://www.who.int/mediacentre/factsheets/fs194/en/ (accessed April 2019);
▶️ World Health Organization. The evolving threat of antimicrobial resistance. Options for action. 2012. Available at: http://apps.who.int/iris/bitstream/handle/10665/44812/9789241503181_eng.pdf?sequence=1 (accessed April 2019);
▶️ ECDC/EMEA Joint Technical Report: The bacterial challenge: time to react. 2009. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf (accessed April 2019);
▶️ van Duijn HJ, et al. Br J Gen Pract 2007;57:561–8;
▶️ World Health Organization. Global action plan on antimicrobial resistance, 2015. Available at: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/ accessed April 2019);
▶️ Zaman SB, et al. Cureus 2017;9:e1403
▶️ der Velden AW, et al. Int J Clin Pract Suppl 2013;10–6
▶️ Essack S, Pignatari AC. Int J Clin Pract 2013;67(Suppl 180):4–9
▶️ Van Duijn HJ, y col. Br J Gen Pract 2007; 57: 561–8;
▶️ Kenealy T, Arroll B. Cochrane Database Syst Rev 2013; 6: CD000247; 3. Ebell MH y col. JAMA 2000; 284: 2912–8;
▶️ Hildreth CJ, y col. JAMA 2009; 302: 816;
▶️ Spinks A, y col. Base de datos Cochrane Syst Rev 2013; 11: CD000023;
▶️ Wilton L, y col. Drug Saf 2003; 26: 589–97; 7. Bergogne-Bérèzin E. Int J Antimicrob Agents 2000; 16: 521–6;
▶️ Costelloe C, y col. BMJ 2010; 340: c2096
▶️ Van der Velden AW, et al. Int J Clin Pract 2013;67(Suppl 180):10–6
▶️ Van Duijn HJ, et al. Br J Gen Pract 2007;57:561–8;
▶️ National Institute for Health and Care Excellence. Respiratory tract infections (self-limiting): prescribing antibiotics. Clinical guideline 69. July 2008. Available at: https://www.nice.org.uk/guidance/cg69 (accessed April 2019);
▶️ van der Velden A, et al. Poster presented at the International Conference on One Health Antimicrobial Resistance (ICOHAR), Utrecht, The Netherlands, 16–18 April 2019;
▶️ van Driel, ML, et al. Ann Fam Med 2006;4:494–9
▶️ Costelloe C, et al. BMJ 2010;340:c2096;
▶️ Kim SH, et al. Antimicrob Agents Chemother 2012;56:1418–26;
▶️ World Health Organization. Antimicrobial resistance. Factsheet 194 Available at: http://www.who.int/mediacentre/factsheets/fs194/en/ (accessed April 2019);
▶️ World Health Organization. The evolving threat of antimicrobial resistance. Options for action. 2012. Available at: http://apps.who.int/iris/bitstream/handle/10665/44812/9789241503181_eng.pdf?sequence=1 (accessed April 2019);
▶️ ECDC/EMEA Joint Technical Report: The bacterial challenge: time to react. 2009. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf (accessed April 2019);
▶️ van Duijn HJ, et al. Br J Gen Pract 2007;57:561–8;
▶️ World Health Organization. Global action plan on antimicrobial resistance, 2015. Available at: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/ accessed April 2019);
▶️ Zaman SB, et al. Cureus 2017;9:e1403
▶️ der Velden AW, et al. Int J Clin Pract Suppl 2013;10–6
▶️ Essack S, Pignatari AC. Int J Clin Pract 2013;67(Suppl 180):4–9
▶️ Van Duijn HJ, y col. Br J Gen Pract 2007; 57: 561–8;
▶️ Kenealy T, Arroll B. Cochrane Database Syst Rev 2013; 6: CD000247;
▶️ Ebell MH y col. JAMA 2000; 284: 2912–8; 4. Hildreth CJ, y col. JAMA 2009; 302: 816;
▶️ Spinks A, y col. Base de datos Cochrane Syst Rev 2013; 11: CD000023;
▶️ Wilton L, y col. Drug Saf 2003; 26: 589–97;
▶️ Bergogne-Bérèzin E. Int J Antimicrob Agents 2000; 16: 521–6;
▶️ Costelloe C, y col. BMJ 2010; 340: c2096